Novavax, Inc. (NVAX) is a biotechnology company engaged in developing innovative vaccines to prevent serious infectious diseases. Novavax’s coronavirus vaccine, NVX-CoV2373, is currently approved for use in the European Union (EU), Indonesia and the Philippines.

Image Source: PixaBay

Regulatory applications seeking approval for the vaccine are currently under review in several countries. Novavax is also looking to file a regulatory application for its influenza vaccine candidate, NanoFlu, shortly. If approved, the company believes that NanoFlu will be a game changer for the prevention of influenza. Shares of Novavax have significantly outperformed the industry in the past year. The company has a favorable debt profile also.

Video Length: 00:11:11

Alight Inc. (ALIT) is a cloud-based provider of integrated digital human capital and business solutions. ALIT works with companies across the world regardless of size, including 70% of Fortune 100 companies. Superb forward-looking cloud-transformation progress from Alight in its 2nd ever quarterly report drove the stock up in its daily post-earnings action (11/9). Management rose its Q4 guidance with its cloud transition going more fluid than the company initially projected. I suspect that more analysts will distribute initiation of coverage reports on the stock with bullish outlooks that align with the company's compelling growth narrative. This is an under-the-radar cloud transformation stock with upside momentum for 2022.